Treatment of Metastatic Breast Cancer in a Real-World Scenario: Is Progression-Free Survival With First Line Predictive of Benefit From Second and Later Lines?

INTRODUCTION. Despite the availability of several therapeutic options for metastatic breast cancer (MBC), no robust predictive factors are available to help clinical decision making. Nevertheless, a decreasing benefit from first line to subsequent lines of treatment is commonly observed. The aim of...

Full description

Saved in:
Bibliographic Details
Published in:Oncologist
Main Authors: Bonotto, Marta, Gerratana, Lorenzo, Iacono, Donatella, Minisini, Alessandro Marco, Rihawi, Karim, Fasola, Gianpiero, Puglisi, Fabio
Format: Artigo
Language:Inglês
Published: AlphaMed Press 2015
Subjects:
Breast Cancer
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4492241/
https://ncbi.nlm.nih.gov/pubmed/26018662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0002
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items